Drug Topics

APRIL 4, 2025

Patients treated with the therapy showed significantly less progression of structural damage compared to patients who received placebo at week 24.

447

447

STAT

APRIL 4, 2025

After Hurricane Ian, as Floridians returned home to sodden furniture and moldy piles of debris, many with asthma could feel their chests tightening. To figure out what was safe, some sent their concerns directly to the U.S. Centers for Disease Control and Prevention.  But on Tuesday — days before floods ravaged Nashville, potentially prompting similar queries — the people who would normally answer such asthma questions stopped working.

145

145

Drug Topics

APRIL 4, 2025

Researchers explored how entrustable professional activities can revolutionize workplace-based training and evolve the role of pharmacists within dermatology clinics.

430

430

STAT

APRIL 4, 2025

In a rare move, the Food and Drug Administration told an unspecified number of drug companies that studies used to support therapeutic equivalence of some of their medicines have been rejected due to false data generated by a contract research organization. The agency identified “significant” problems with data integrity and the way studies were conducted by Raptim Research, which had been hired by the drugmakers to test their medicines.

FDA 143

FDA Pharmaceutical Companies Pharmaceutical Companies 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

APRIL 4, 2025

Researchers conducted a study to understand how community pharmacist referrals translated to the acceptance and completion of annual wellness visits.

415

415

STAT

APRIL 4, 2025

Food has been front and center in the Make America Healthy Again movement, Health Secretary Robert F. Kennedy Jr.’s campaign to solve chronic disease in the United States. That’s why forthcoming federal guidance on nutrition could draw extra attention this time around, even as a massive reorganization of the nation’s health workforce unfolds.

114

114

STAT

APRIL 4, 2025

As a longtime dog owner, I assumed that each bag of my dogs’ commercial pet food was closely monitored by the federal Food and Drug Administration (FDA). It turns out I was wrong. More than 102 million U.S. households own a dog or a cat, and thousands more have fish, birds, or reptiles. The resulting pet food industry is massive — Americans spent $65 billion on pet food and treats in 2023 alone.

FDA 108

FDA 108

Drug Topics

APRIL 4, 2025

As pharmacists adapt to patient needs, pharmacists' mental wellness remains critical.

341

341

STAT

APRIL 4, 2025

Hello. Today, we dive into the implications of the ongoing cuts to various health and science agencies… It’s a doozy. Oh, and if you like talking about neuroscience and happen to be near San Diego this weekend, come hang with me and my colleagues at STAT@AAN : The Future of Brain Health.

109

109

Drug Topics

APRIL 4, 2025

Clinical pharmacists counsel patients during the intervention and make informed medication changes based on the data received from continuous glucose monitoring (CGM).

315

315

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 4, 2025

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

Immunization 90

Immunization 90

Drug Topics

APRIL 4, 2025

Jenny Markell, BA, discussed the ongoing trends in prescription drug advertising and touched on her research into the impact it has on consumers.

315

315

European Pharmaceutical Review

APRIL 4, 2025

New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.

64

64

Drug Topics

APRIL 4, 2025

Pharmacists are transforming health care delivery by breaking down traditional barriers to medication access and patient care.

Patient Care 247

Patient Care 247

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

APRIL 4, 2025

Isomorphic Labs recently raked in $600 million to help develop its drug discovery platform.

182

182

European Pharmaceutical Review

APRIL 4, 2025

Analytical testing is an essential part of guaranteeing the quality, safety and effectiveness of pharmaceutical products. However, the process is not without its challenges and it requires a proactive approach if both compliance and efficiency are to be maintained. This is why it is essential to develop and validate analytical methods to support activities and functions such as process validation controls, stability tests and dissolution profiles.

Dosage 64

Dosage Packaging FDA Communication 64

Pharmafile

APRIL 4, 2025

A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that demonstrated a significant improvement in live birth rates. Prometrium, a 400mg soft vaginal capsule developed by Besins Healthcare, is now available in England, Wales, Scotland and Northern Ireland. It is designed for use by women […] The post New hormonal treatment launched to help prevent miscarriage in early pregnancy appeared first on Pharmafile.

59

59

Pharma Marketing Network

APRIL 4, 2025

In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Rather than relying solely on paid ads or direct promotion, referral marketing uses personal recommendations to generate awareness, interest, and ultimately, conversions.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

APRIL 4, 2025

Bonjesta is a brand-name prescription drug used to treat nausea and vomiting associated with pregnancy. This medication is an oral tablet that contains the medicines doxylamine and pyridoxine (a form of vitamin B6 ). Currently, there is not a generic version of Bonjesta. Managing nausea and vomiting during pregnancy is usually first controlled with diet and lifestyle adjustments.

Insurance 52

Insurance Health and Personal Care Stores Insurance Coverage Documentation 52

Pharmafile

APRIL 4, 2025

Mehilinen, a Finnish health and social care provider, has announced that it has agreed to acquire Regina Maria and MediGroup. In conjunction with these, Hellman & Friedman (H&F) joins CVC in an investment partnership in the company. These developments form part of Mehilinens international growth strategy which focuses on expanding both in Finland and in […] The post Mehilinen acquires Regina Maria and MediGroup, and welcomes Hellman & Friedman as new shareholder appeared first

59

59

PharmaVoice

APRIL 4, 2025

Dr. Mehmet Oz, a physician and TV personality, will lead the agency during a turbulent time for federal health programs as the HHS lays off thousands of staffers and Republicans float potential cuts to Medicaid.

130

130

The Checkup by Singlecare

APRIL 4, 2025

Abilify (aripiprazole ) is a second-generation antipsychotic medicine used primarily in the treatment of bipolar disorder , schizophrenia , and depression. S econd-generation antipsychotics possess mood-stabilizing potential to go along with a lower risk of side effects than first-generation antipsychotics and an array of dosage forms. Efficacy, fewer adverse events, and convenience sound like an enticing trio of features, but Abilify may not be the best choice among the group.

Dosage 52

Dosage Labelling 52

Pharmafile

APRIL 4, 2025

Bristol Myers Squibb (BMS) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its immunotherapy drug Opdivo (nivolumab), marking a major step towards expanding treatment options for patients with resectable non-small cell lung cancer (NSCLC) in the EU. CHMP, part of the European Medicines Agency (EMA), has recommended […] The post Bristol Myers Squibb receives positive CHMP opinion for Opdivo treatment appeared first on Pharmafile.

59

59

Pharmacy Times

APRIL 4, 2025

Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.

Compounding Pharmacies 121

Compounding Pharmacies Compounding 121

The Checkup by Singlecare

APRIL 4, 2025

Semaglutide (the active ingredient in brand-name drugs Ozempic , Rybelsus , and Wegovy ) is a GLP-1 receptor agonist , antidiabetic, and weight loss drug. The injectable medicine, Ozempic, is approved by the U.S. Food and Drug Administration (FDA) to treat Type 2 diabetes and lower the risk of cardiovascular events and kidney problems in certain adults.

Compounding 52

Compounding Insurance Insurance Coverage Dosage 52

Pharmacy Times

APRIL 4, 2025

The new designations span both warm autoimmune hemolytic anemia and IgG4-related disease, 2 rare, immune-mediated conditions that burden patients due to a lack of available treatment options.

Immunization 113

Immunization 113

Pharmaceutical Technology

APRIL 4, 2025

The EC has approved Daiichi Sankyo and AstraZenecas Enhertu for use as a single agent to treat adults with certain breast cancers.

109

109

Pharmacy Times

APRIL 4, 2025

BIIB080 is designed to target microtubule-associated protein tau mRNA, aimed to reduce the production of tau protein.

FDA 110

FDA 110

pharmaphorum

APRIL 4, 2025

Amgen has bagged a second indication for its B cell-depleting therapy Uplizna after the FDA cleared it for rare inflammatory disease IgG4-RD

FDA 99

FDA 99

Pharmaceutical Technology

APRIL 4, 2025

Streeting said his June 10-year plan will address drug sale clawbacks, NICE regulation, and the abolition of NHS England.

98

98

Fierce Healthcare

APRIL 4, 2025

Experts spoke out about the impact these and future potential cuts will have on underserved patients around the U.S.

97

97

Pharmacy Times

APRIL 4, 2025

CAV-1 is a key protein in lipid rafts that helps control cellular processes such as growth, survival, and migration.

82

82

Fierce Healthcare

APRIL 4, 2025

Rural areas are quickly losing independent physicians and medical practices amid the corporatization of healthcare, a new report finds. | The number of independent doctors in rural areas fell 43% from 2019 through 2023, while rural areas lost 5% of all practicing physicians.

90

90